- Home
- RCKT vs IONQ Comparison
RCKT vs IONQ Comparison
Compare RCKT & IONQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- IONQ
- Stock Information
- Founded
- RCKT 1999
- IONQ 2015
- Country
- RCKT United States
- IONQ United States
- Employees
- RCKT N/A
- IONQ N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- IONQ Wholesale Distributors
- Sector
- RCKT Health Care
- IONQ Industrials
- Exchange
- RCKT Nasdaq
- IONQ Nasdaq
- Market Cap
- RCKT 1.9B
- IONQ 1.5B
- IPO Year
- RCKT N/A
- IONQ N/A
- Fundamental
- Price
- RCKT $18.51
- IONQ $6.80
- Analyst Decision
- RCKT Strong Buy
- IONQ Strong Buy
- Analyst Count
- RCKT 9
- IONQ 5
- Target Price
- RCKT $53.22
- IONQ $13.00
- AVG Volume (30 Days)
- RCKT 655.8K
- IONQ 3.6M
- Earning Date
- RCKT 08-05-2024
- IONQ 08-07-2024
- Dividend Yield
- RCKT N/A
- IONQ N/A
- EPS Growth
- RCKT N/A
- IONQ N/A
- EPS
- RCKT N/A
- IONQ N/A
- Revenue
- RCKT N/A
- IONQ $31,205,000.00
- Revenue This Year
- RCKT N/A
- IONQ $87.41
- Revenue Next Year
- RCKT $300.20
- IONQ $97.26
- P/E Ratio
- RCKT N/A
- IONQ N/A
- Revenue Growth
- RCKT N/A
- IONQ 90.62
- 52 Week Low
- RCKT $15.27
- IONQ $6.22
- 52 Week High
- RCKT $32.53
- IONQ $21.60
- Technical
- Relative Strength Index (RSI)
- RCKT 42.14
- IONQ 42.46
- Support Level
- RCKT $17.59
- IONQ $6.78
- Resistance Level
- RCKT $19.30
- IONQ $7.24
- Average True Range (ATR)
- RCKT 0.86
- IONQ 0.35
- MACD
- RCKT 0.06
- IONQ -0.03
- Stochastic Oscillator
- RCKT 34.59
- IONQ 8.33
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
About IONQ IonQ Inc.
IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems, and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.